Chemours Co. Files 8-K with Financial Obligations

TL;DR

Chemours just filed an 8-K detailing new financial obligations. Watch for details.

AI Summary

On December 13, 2024, The Chemours Company entered into a material definitive agreement related to financial obligations. This filing also includes Regulation FD disclosures and financial statements/exhibits.

Why It Matters

This filing indicates new or updated financial commitments for Chemours, which could impact its financial health and investor outlook.

Risk Assessment

Risk Level: medium — Material definitive agreements and financial obligations can introduce new risks or alter existing ones for a company.

Key Players & Entities

• The Chemours Company (company) — Registrant
• Delaware (location) — State of Incorporation
• December 13, 2024 (date) — Date of Report

FAQ

Key Financial Figures

• $0.01 — nge on Which Registered Common Stock ($0.01 par value) CC New York Stock Exchan

Filing Documents

• cc-20241213.htm (8-K) — 53KB
• cc-ex10_1.htm (EX-10.1) — 104KB
• cc-ex99_1.htm (EX-99.1) — 17KB
• img15408389_0.jpg (GRAPHIC) — 37KB
• img172711888_0.jpg (GRAPHIC) — 35KB
• 0000950170-24-136240.txt ( ) — 445KB
• cc-20241213.xsd (EX-101.SCH) — 29KB
• cc-20241213_htm.xml (XML) — 4KB

01

Item 1.01 Entry into a Material Definitive Agreement. On December 13, 2024, The Chemours Company (the "Company") entered into Amendment No. 2 (the "Second Amendment") among the Company, certain subsidiaries of the Company, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the "Administrative Agent"), which amends the Second Amended and Restated Credit Agreement, dated as of August 18, 2023, among the Company, the lenders from time to time party thereto and the Administrative Agent (as amended by Amendment No. 1, dated as of November 29, 2024 and as further amended, supplemented or otherwise modified from time to time prior to December 13, 2024, the "Existing Credit Agreement"). The Second Amendment reduces the applicable margin in respect of the Company's 415,000,000 Euro denominated term loan facility (the "Tranche B-3 Euro Term Loan Facility") from adjusted EURIBOR + 4.00% to adjusted EURIBOR + 3.25%. There are no changes to the maturity of the Term B-3 Euro Term Loan Facility following this repricing, and all other terms are substantially unchanged. Capitalized terms used in this Item 1.01 but not otherwise defined herein have the meanings assigned to them in the Existing Credit Agreement as amended. The foregoing description of the Second Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Second Amendment which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

03

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under Off-Balance Sheet Arrangement of a Registrant. The information set forth in Item 1.01 is incorporated herein by reference.

01

Item 7.01 Regulation FD Disclosure. On December 13, 2024, the Company issued a press release announcing entry into the Second Amendment. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit 10.1 Amendment No. 2, dated as of December 13, 2024, among The Chemours Company, the other Loan Parties, and the Lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent, to the Second Amended and Restated Credit Agreement dated as of August 18, 2023 Exhibit 99.1 Press release dated as of December 13, 2024 issued by the Chemours Company Exhibit 104 Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CHEMOURS COMPANY By: /s/ Shane Hostetter Shane Hostetter Senior Vice President, Chief Financial Officer Date: December 13, 2024

View Full Filing

View this 8-K filing on SEC EDGAR